Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial

BACKGROUND: Lung cancer is the most common cause of cancer related death worldwide. The majority of cases are detected at a late stage when prognosis is poor. The EarlyCDT®-Lung Test detects autoantibodies to abnormal cell surface proteins in the earliest stages of the disease which may allow tumour...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Sullivan, F. M., Farmer, Eoghan, Mair, Frances S., Treweek, Shaun, Kendrick, Denise, Jackson, Cathy, Robertson, Chris, Briggs, Andrew, McCowan, Colin, Bedford, Laura, Young, Ben, Vedhara, Kavita, Gallant, Stephanie, Littleford, Roberta, Robertson, John, Sewell, Herb, Dorward, Alistair, Sarvesvaran, Joseph, Schembri, Stuart
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346215/
https://ncbi.nlm.nih.gov/pubmed/28284200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3175-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki